I learned about a new study that finds the U.S. is facing serious challenges to maintaining its position as the global leader in medical innovation. The study Gone Tomorrow? A Call to Promote Medical Innovation, Create Jobs, and Find Cures in America was commissioned by the Council for American Medical Innovation (CAMI), which views leadership in medical innovation as a key part of addressing the health and economic crisis in the U.S.

What does this mean for a company like Johnson & Johnson? Joaquin Duato, Company Group Chairman, Pharmaceuticals—The Americas, spoke at a We Work for Health event at Rutgers University about the importance of medical innovation and how our pharmaceutical business is working to further innovation. He emphasized the significance of collaboration between public and private sectors at all levels of development to address unmet medical needs around the world. Joaquin also highlighted an important external factor that impacts medical innovation—policies that support leadership and investment in the life sciences, which in turn spur innovation, create jobs and improve the lives of patients. You can read his full remarks here.